Drug Type Cell therapy |
Synonyms HB601 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization Hysensbio Co., Ltd.Startup |
Active Organization Hysensbio Co., Ltd.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Age Related Macular Degeneration | Discovery | KR | Hysensbio Co., Ltd.Startup | 01 Nov 2024 |
Nonalcoholic Steatohepatitis | Discovery | KR | Hysensbio Co., Ltd.Startup | 12 Oct 2022 |